Dr Pierpaolo Pellicori

  • Clinical Senior Lecturer/Honorary Consultant (Robertson Centre for Biostatistics)

Publications

List by: Type | Date

Jump to: 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012
Number of items: 121.

2022

Pellicori, P. , McConnachie, A. , Carlin, C., Wales, A. and Cleland, J. G.F. (2022) Predicting mortality after hospitalisation for COPD using electronic health records. Pharmacological Research, 179, 106199. (doi: 10.1016/j.phrs.2022.106199) (PMID:35381341)

Rastogi, T., Bozec, E., Pellicori, P. , Bayes Genis, A., Coiro, S., Domingo, M., Gargani, L., Palazzuoli, A. and Girerd, N. (2022) Prognostic value and therapeutic utility of lung ultrasound in acute and chronic heart failure: a meta-analysis. JACC: Cardiovascular Imaging, 15(5), pp. 950-952. (doi: 10.1016/j.jcmg.2021.11.024) (PMID:35033496)

Verdonschot, J. A.J. et al. (2022) The effect of spironolactone in patients with obesity at risk for heart failure: proteomic insights from the HOMAGE trial. Journal of Cardiac Failure, 28(5), pp. 778-786. (doi: 10.1016/j.cardfail.2021.12.005) (PMID:34933097)

Pellicori, P. and Cleland, J. G. F. (2022) Heart failure: age is no excuse for complacency. European Journal of Heart Failure, (doi: 10.1002/ejhf.2517) (PMID:35481861) (Early Online Publication)

Girerd, N. et al. (2022) Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction. ESC Heart Failure, (doi: 10.1002/ehf2.13929) (PMID:35429120) (Early Online Publication)

Girerd, N. et al. (2022) Practical outpatient management of worsening chronic heart failure. European Journal of Heart Failure, (doi: 10.1002/ejhf.2503) (PMID:35417093) (Early Online Publication)

Rastogi, T. et al. (2022) Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank. European Journal of Heart Failure, (doi: 10.1002/ejhf.2495) (PMID:35365899) (Early Online Publication)

Cleland, J. G.F. , Butler, J., Januzzi, J. L., Pellicori, P. and McDonagh, T. (2022) Only people with increased plasma concentrations of natriuretic peptides should be included in outcome trials of diabetes, cardiovascular and kidney disease: implications for clinical practice. European Journal of Heart Failure, 24(4), pp. 678-680. (doi: 10.1002/ejhf.2488) (PMID:35297132)

Ferreira, J. P. et al. (2022) Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial. European Heart Journal: Cardiovascular Pharmacotherapy, 8(2), pp. 149-156. (doi: 10.1093/ehjcvp/pvab031) (PMID:33822033)

Pellicori, P. , Vaduganathan, M., Ferreira, J. P., Zannad, F. and Sanyal, A. J. (2022) Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design. Diabetes and Metabolism, 48(2), 101281. (doi: 10.1016/j.diabet.2021.101281) (PMID:34543735)

Ferreira, J. P. et al. (2022) Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial. European Journal of Heart Failure, (doi: 10.1002/ejhf.2455) (PMID:35199421) (Early Online Publication)

Masini, G., Graham, F. J., Pellicori, P. , Cleland, J. G.F. , Cuthbert, J. J., Kazmi, S., Inciardi, R. M. and Clark, A. L. (2022) Criteria for iron deficiency in patients with heart failure. Journal of the American College of Cardiology, 79(4), pp. 341-351. (doi: 10.1016/j.jacc.2021.11.039) (PMID:35086656)

Caiazzo, E., Rezig, A. O.M. , Bruzzese, D., Ialenti, A., Cicala, C., Cleland, J. G.F. , Guzik, T. J., Maffia, P. and Pellicori, P. (2022) Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: a systematic review and meta-analysis of randomised trials. Pharmacological Research, 176, 106053. (doi: 10.1016/j.phrs.2021.106053) (PMID:34979235) (PMCID:PMC8719379)

Ravassa, S. et al. (2022) Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial. European Journal of Heart Failure, 24(2), pp. 321-331. (doi: 10.1002/ejhf.2394) (PMID:34841615)

Mesin, L. et al. (2022) Assessment of phasic changes of vascular size by automated edge tracking-state of the art and clinical perspectives. Frontiers in Cardiovascular Medicine, 8, 775635. (doi: 10.3389/fcvm.2021.775635) (PMID:35127855) (PMCID:PMC8814097)

Cuthbert, J.J. et al. (2022) Hypochloraemia following admission to hospital with heart failure is common and associated with an increased risk of readmission or death: a report from OPERA-HF. European Heart Journal: Acute Cardiovascular Care, 11(1), pp. 43-52. (doi: 10.1093/ehjacc/zuab097) (PMID:34897402)

2021

Ferreira, J. P., Girerd, N., Rocca, H.-P. B.-L., Pellicori, P. , Cleland, J. G. , Rossignol, P. and Zannad, F. (2021) No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial = Pas d’influence de la spironolactone sur les concentrations plasmatiques de l’enzyme de conversion de l’angiotensine 2 : résultats de l’essai randomisé HOMAGE. Archives of Cardiovascular Diseases, 114(12), pp. 814-817. (doi: 10.1016/j.acvd.2021.10.003) (PMID:34772647) (PMCID:PMC8576594)

Cuthbert, J. J., Pellicori, P. , Flockton, R., Kallvikbacka-Bennett, A., Khan, J., Rigby, A. S., Girerd, N., Zannad, F., Cleland, J. G.F. and Clark, A. L. (2021) The prevalence and clinical associations of ultrasound measures of congestion in patients at risk of developing heart failure. European Journal of Heart Failure, 23(11), pp. 1831-1840. (doi: 10.1002/ejhf.2353) (PMID:34632680)

Pan, D. et al. (2021) Prognostic value of the chest x-ray in patients hospitalised for heart failure. Clinical Research in Cardiology, 110(11), pp. 1743-1756. (doi: 10.1007/s00392-021-01836-9) (PMID:33754159)

Anderson, J. J. et al. (2021) Remote history of VTE is associated with severe COVID-19 in middle and older age: UK Biobank cohort study. Journal of Thrombosis and Haemostasis, 19(10), pp. 2533-2538. (doi: 10.1111/jth.15452) (PMID:34242477) (PMCID:PMC8420476)

Graham, F. J., Pellicori, P. , Cleland, J. G.F. and Clark, A. L. (2021) Reply to the letter regarding the article 'Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure'. European Journal of Heart Failure, 23(10), pp. 1800-1801. (doi: 10.1002/ejhf.2304) (PMID:34263510)

Shah, P., Abel, A. A.I., Boyalla, V., Pellicori, P. , Kallvikbacka-Bennett, A., Sze, S., Cleland, J. G.F. and Clark, A. L. (2021) A comparison of non-invasive methods of measuring body composition in patients with heart failure: a report from SICA-HF. ESC Heart Failure, 8(5), pp. 3929-3934. (doi: 10.1002/ehf2.13402) (PMID:34216106) (PMCID:PMC8497207)

Cleland, J. G.F. and Pellicori, P. (2021) To master heart failure, first master congestion. Lancet, 398(10304), pp. 935-936. (doi: 10.1016/S0140-6736(21)01914-0) (PMID:34461039)

Pellicori, P. and Cleland, J. G.F. (2021) Structural heart disease, cardiac dysfunction and heart failure: the ambiguity of a definition. European Journal of Preventive Cardiology, 28(9), pp. 921-923. (doi: 10.1177/2047487320937135) (PMID:32718235)

Verdonschot, J. A.J. et al. (2021) Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial. Cardiovascular Diabetology, 20, 163. (doi: 10.1186/s12933-021-01357-9)

Castrichini, M., Nuzzi, V., Sinagra, G., Cleland, J. and Pellicori, P. (2021) Use of social media by cardiovascular health care professionals: is patient privacy respected? JACC: Cardiovascular Imaging, 14(8), pp. 1680-1682. (doi: 10.1016/j.jcmg.2021.02.012) (PMID:34023252)

Cleland, J. G.F. , Pellicori, P. and González, A. (2021) A novel treatment for heart failure targets myocardial fibrosis. Nature Medicine, 27(8), pp. 1343-1344. (doi: 10.1038/s41591-021-01457-9) (PMID:34385705)

Graham, F. J., Pellicori, P. , Ford, I. , Petrie, M. C. , Kalra, P. R. and Cleland, J. G.F. (2021) Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials. Clinical Research in Cardiology, 110(8), pp. 1299-1307. (doi: 10.1007/s00392-021-01837-8) (PMID:33755777)

Kobayashi, M. et al. (2021) Association between right-sided cardiac function and ultrasound-based pulmonary congestion on acutely decompensated heart failure findings from a pooled analysis of four cohort studies. Clinical Research in Cardiology, 110(8), pp. 1181-1192. (doi: 10.1007/s00392-020-01724-8) (PMID:32770373)

Pellicori, P. et al. (2021) Use of diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA-REG OUTCOME trial. European Journal of Heart Failure, 23(7), pp. 1085-1093. (doi: 10.1002/ejhf.2220) (PMID:34031968)

Cleland, J. G.F. et al. (2021) The struggle towards a universal definition of heart failure—how to proceed? European Heart Journal, 42(24), pp. 2331-2343. (doi: 10.1093/eurheartj/ehab082) (PMID:33791787)

Pandhi, P. et al. (2021) The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failure. Journal of Cachexia, Sarcopenia and Muscle, 12(3), pp. 555-567. (doi: 10.1002/jcsm.12690) (PMID:33742549)

Graham, F. J., Masini, G., Pellicori, P. , Cleland, J. G.F. , Greenlaw, N., Friday, J., Kazmi, S. and Clark, A. L. (2021) Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure. European Journal of Heart Failure, (doi: 10.1002/ejhf.2251) (PMID:34050582) (Early Online Publication)

Pellicori, P. et al. (2021) Ultrasound imaging of congestion in heart failure – examinations beyond the heart. European Journal of Heart Failure, 23(5), pp. 703-712. (doi: 10.1002/ejhf.2032) (PMID:33118672)

Zhang, J., Pellicori, P. , Schutte, R. and Cleland, J.G. (2021) The association between blood groups and COVID-19 infection: a study from the UK Biobank. Journal of Internal Medicine, 289(5), pp. 747-748. (doi: 10.1111/joim.13226) (PMID:33306225)

Ferreira, J. P. et al. (2021) Proteomic and mechanistic analysis of spironolactone in patients at risk for HF. JACC: Heart Failure, 9(4), pp. 268-277. (doi: 10.1016/j.jchf.2020.11.010) (PMID:33549556)

Pellicori, P. et al. (2021) COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database of Systematic Reviews, 2021(3), CD013879. (doi: 10.1002/14651858.CD013879) (PMID:33704775)

Sze, S., Pellicori, P. , Zhang, J., Weston, J. and Clark, A. L. (2021) The impact of malnutrition on short-term morbidity and mortality in ambulatory patients with heart failure. American Journal of Clinical Nutrition, 113(3), pp. 695-705. (doi: 10.1093/ajcn/nqaa311) (PMID:33236050)

Cleland, J. G.F. et al. (2021) The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial. European Heart Journal, 42(6), pp. 684-696. (doi: 10.1093/eurheartj/ehaa758) (PMID:33215209) (PMCID:PMC7878013)

Anderson, J. J. et al. (2021) Ethnic differences in prevalence of actionable HbA1c levels in UK Biobank: implications for screening. BMJ Open Diabetes Research and Care, 9(1), e002176. (doi: 10.1136/bmjdrc-2021-002176) (PMID:34353880) (PMCID:PMC8344314)

Shah, P., Pellicori, P. , Hanning, I., Zhang, J., Clark, A. L. and Bhandari, S. (2021) The effect of digoxin on renal function in patients with heart failure. BMC Nephrology, 22(1), 349. (doi: 10.1186/s12882-021-02562-0) (PMCID:PMC8549227)

2020

Pellicori, P. , Ofstad, A. P., Fitchett, D., Zeller, C., Wanner, C., George, J., Zinman, B., Brueckmann, M. and Lindenfeld, J. (2020) Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA-REG OUTCOME. ESC Heart Failure, 7(6), pp. 3401-3407. (doi: 10.1002/ehf2.12891) (PMID:32915523) (PMCID:PMC7754994)

Palazzuoli, A., Ruocco, G., Franci, B., Evangelista, I., Lucani, B., Nuti, R. and Pellicori, P. (2020) Ultrasound indices of congestion in patients with acute heart failure according to body mass index. Clinical Research in Cardiology, 109(11), pp. 1423-1433. (doi: 10.1007/s00392-020-01642-9) (PMID:32296972)

Pellicori, P. et al. (2020) Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial. European Journal of Heart Failure, 22(9), pp. 1711-1723. (doi: 10.1002/ejhf.1716) (PMID:31950604)

Voors, A. A. et al. (2020) Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial. European Journal of Heart Failure, 22(9), pp. 1649-1658. (doi: 10.1002/ejhf.1933) (PMID:32558989) (PMCID:PMC7689751)

Pan, D., Pellicori, P. , Walklett, C., Green, A., Masse, A. R., Wood, J., Purdy, J. and Clark, A. L. (2020) Driving habits and reaction times on a driving simulation in older drivers with chronic heart failure. Journal of Cardiac Failure, 26(7), pp. 555-563. (doi: 10.1016/j.cardfail.2020.04.002) (PMID:32433933)

Cleland, J. G.F. , Clark, R. A., Pellicori, P. and Inglis, S. C. (2020) Caring for people with heart failure and many other medical problems through and beyond the COVID‐19 pandemic; the advantages of universal‐access to home telemonitoring. European Journal of Heart Failure, 22(6), pp. 995-998. (doi: 10.1002/ejhf.1864) (PMID:32385954) (PMCID:PMC7273055)

Sze, S., Pellicori, P. , Zhang, J., Weston, J. and Clark, A. (2020) Agreement and classification performance of malnutrition tools in patients with chronic heart failure. Current Developments in Nutrition, 4(6), nzaa071. (doi: 10.1093/cdn/nzaa071) (PMID:32529169) (PMCID:PMC7272189)

Pellicori, P. (2020) At the heart of COVID-19. European Heart Journal, 41(19), pp. 1830-1832. (doi: 10.1093/eurheartj/ehaa415) (PMID:32405639)

Hayes, S. et al. (2020) Association between walking pace and stroke incidence: findings from the UK Biobank prospective cohort study. Stroke, 51(5), pp. 1388-1395. (doi: 10.1161/STROKEAHA.119.028064) (PMID:32299326)

Stienen, S., Ferreira, J. P., Pitt, B., Cleland, J. G. , Pellicori, P. , Girerd, N., Rossignol, P. and Zannad, F. (2020) Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure. European Journal of Heart Failure, 22(5), pp. 901-903. (doi: 10.1002/ejhf.1812) (PMID:32243646)

Pellicori, P. , Cleland, J. G.F. and Clark, A. L. (2020) Chronic obstructive pulmonary disease and heart failure: a breathless conspiracy. Heart Failure Clinics, 16(1), pp. 33-44. (doi: 10.1016/j.hfc.2019.08.003) (PMID:31735313)

Pellicori, P. , Khan, M. J. I., Graham, F. J. and Cleland, J. G.F. (2020) New perspectives and future directions in the treatment of heart failure. Heart Failure Reviews, 25, pp. 147-159. (doi: 10.1007/s10741-019-09829-7) (PMID:31327116) (PMCID:PMC6985084)

Pellicori, P. , Zhang, J., Cuthbert, J., Urbinati, A., Shah, P., Kazmi, S., Clark, A. L. and Cleland, J. G.F. (2020) High sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death. Cardiovascular Research, 116(1), pp. 91-100. (doi: 10.1093/cvr/cvz198) (PMID:31350553)

2019

Pellicori, P. , Urbinati, A., Kaur, K., Zhang, J., Shah, P., Kazmi, S., Capucci, A., Cleland, J. G.F. and Clark, A. L. (2019) Prevalence and incidence of atrial fibrillation in ambulatory patients with heart failure. American Journal of Cardiology, 124(10), pp. 1554-1560. (doi: 10.1016/j.amjcard.2019.08.018) (PMID:31558271)

Sillars, A. et al. (2019) Association of fitness and grip-strength with heart failure: findings from the UK Biobank population-based study. Mayo Clinic Proceedings, 94(11), pp. 2230-2240. (doi: 10.1016/j.mayocp.2019.04.041) (PMID:31685151)

Cleland, J. G.F. and Pellicori, P. (2019) Myocardial dysfunction and coronary artery disease as therapeutic targets in heart failure. Circulation, 140(7), pp. 538-541. (doi: 10.1161/CIRCULATIONAHA.119.041523) (PMID:31403847)

Nuzzi, V. et al. (2019) Clinical and prognostic association of total atrial conduction time in patients with heart failure: a report from Studies Investigating Co-morbidities Aggravating Heart Failure. Journal of Cardiovascular Medicine, 20(7), pp. 442-449. (doi: 10.2459/JCM.0000000000000802) (PMID:30985354)

Pellicori, P. , Shah, P., Cuthbert, J., Urbinati, A., Zhang, J., Kallvikbacka-Bennett, A., Clark, A. L. and Cleland, J. G.F. (2019) Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure. European Journal of Heart Failure, 21(7), pp. 904-916. (doi: 10.1002/ejhf.1383) (PMID:30666769)

Cleland, J. G.F. , Pellicori, P. and Clark, A. L. (2019) Prevention or procrastination for heart failure?: Why we need a universal definition of heart failure. Journal of the American College of Cardiology, 73(19), pp. 2398-2400. (doi: 10.1016/j.jacc.2019.03.471) (PMID:31097158)

Shah, P., Pellicori, P. , Kallvikbacka-Bennett, A., Zhang, J., Pan, D. and Clark, A. L. (2019) Warm water immersion in patients with chronic heart failure: a pilot study. Clinical Research in Cardiology, 108(5), pp. 468-476. (doi: 10.1007/s00392-018-1376-2) (PMID:30267153) (PMCID:PMC6484774)

Sze, S., Pellicori, P. , Zhang, J., Weston, J. and Clark, A. L. (2019) Identification of frailty in chronic heart failure. JACC: Heart Failure, 7(4), pp. 291-302. (doi: 10.1016/j.jchf.2018.11.017) (PMID:30738977)

Celis-Morales, C. A. et al. (2019) Walking pace is associated with lower risk of all-cause and cause-specific mortality. Medicine and Science in Sports and Exercise, 51(3), pp. 472-480. (doi: 10.1249/MSS.0000000000001795) (PMID:30303933)

Palazzuoli, A., Ruocco, G., Pellicori, P. , Incampo, E., Di Tommaso, C., Favilli, R., Evangelista, I., Nuti, R. and Testani, J. M. (2019) The prognostic role of different renal function phenotypes in patients with acute heart failure. International Journal of Cardiology, 276, pp. 198-203. (doi: 10.1016/j.ijcard.2018.11.108) (PMID:30503187)

Bekfani, T. et al. (2019) Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life. Clinical Research in Cardiology, 108(2), pp. 203-211. (doi: 10.1007/s00392-018-1344-x) (PMID:30051186)

Sze, S., Pellicori, P. , Zhang, J. and Clark, A. L. (2019) Malnutrition, congestion and mortality in ambulatory patients with heart failure. Heart, 105(4), pp. 297-306. (doi: 10.1136/heartjnl-2018-313312) (PMID:30121635)

Zhang, J., Begley, A., Jackson, R., Harrison, M., Pellicori, P. , Clark, A. L. and Cleland, J. G.F. (2019) Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose–response meta-analysis. Clinical Research in Cardiology, 108(2), pp. 119-132. (doi: 10.1007/s00392-018-1302-7) (PMID:29951802)

2018

Zhang, J., Pellicori, P. , Pan, D., Dierckx, R., Clark, A.L. and Cleland, J.G.F. (2018) Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure. International Journal of Cardiology, 269, pp. 196-200. (doi: 10.1016/j.ijcard.2018.06.070) (PMID:30001941)

Shah, P., Pellicori, P. , Rimmer, S., Rigby, A. S. and Clark, A. L. (2018) Effect of increased inspired oxygen on exercise performance in patients with heart failure and normal ejection fraction. International Journal of Cardiology, 268, pp. 166-169. (doi: 10.1016/j.ijcard.2018.05.029) (PMID:29803343)

Cuthbert, J. J., Pellicori, P. , Rigby, A., Pan, D., Kazmi, S., Shah, P. and Clark, A. L. (2018) Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance. European Journal of Heart Failure, 20(10), pp. 1426-1435. (doi: 10.1002/ejhf.1247) (PMID:29943886)

Sze, S., Pellicori, P. , Kamzi, S., Anton, A. and Clark, A. L. (2018) Effect of beta-adrenergic blockade on weight changes in patients with chronic heart failure. International Journal of Cardiology, 264, pp. 104-112. (doi: 10.1016/j.ijcard.2018.03.089) (PMID:29628277)

Pellicori, P. , Cleland, J. G.F. and Clark, A. L. (2018) Losing track by tracking speckles. JACC: Cardiovascular Imaging, 11(7), pp. 1038-1039. (doi: 10.1016/j.jcmg.2018.04.027) (PMID:29976301)

Sze, S., Pellicori, P. , Kazmi, S., Rigby, A., Cleland, J. G.F. , Wong, K. and Clark, A. L. (2018) Prevalence and prognostic significance of malnutrition using 3 scoring systems among outpatients with heart failure: a comparison with body mass index. JACC: Heart Failure, 6(6), pp. 476-486. (doi: 10.1016/j.jchf.2018.02.018) (PMID:29753673)

Sokoreli, I., Pauws, S. C., Steyerberg, E. W., de Vries, G.-J., Riistama, J. M., Tesanovic, A., Kazmi, S., Pellicori, P. , Cleland, J. G. and Clark, A. L. (2018) Prognostic value of psychosocial factors for first and recurrent hospitalizations and mortality in heart failure patients: insights from the OPERA-HF study. European Journal of Heart Failure, 20(4), pp. 689-696. (doi: 10.1002/ejhf.1112) (PMID:29314447)

Nikolaidou, T., Pellicori, P. , Zhang, J., Kazmi, S., Goode, K. M., Cleland, J. G. and Clark, A. L. (2018) Prevalence, predictors, and prognostic implications of PR interval prolongation in patients with heart failure. Clinical Research in Cardiology, 107(2), pp. 108-119. (doi: 10.1007/s00392-017-1162-6) (PMID:28917011) (PMCID:PMC5790844)

Pellicori, P. , Urbinati, A., Zhang, J., Joseph, A. C., Costanzo, P., Lukaschuk, E., Capucci, A., Cleland, J. G.F. and Clark, A. L. (2018) Clinical and prognostic relationships of pulmonary artery to aorta diameter ratio in patients with heart failure: a cardiac magnetic resonance imaging study. Clinical Cardiology, 41(1), pp. 20-27. (doi: 10.1002/clc.22840) (PMID:29359813))

2017

Shah, P., Pellicori, P. , Macnamara, A., Urbinati, A. and Clark, A. L. (2017) Is swimming safe in heart failure? A systematic review. Cardiology in Review, 25(6), pp. 321-325. (doi: 10.1097/CRD.0000000000000154) (PMID:28767502)

Cleland, J. G.F. , Pellicori, P. , Clark, A. L. and Petrie, M. C. (2017) Time to take the failure out of heart failure: the importance of optimism. JACC: Heart Failure, 5(7), pp. 538-540. (doi: 10.1016/j.jchf.2017.04.003) (PMID:28624485)

Pellicori, P. , Clark, A. L., Kallvikbacka-Bennett, A., Zhang, J., Urbinati, A., Monzo, L., Dierckx, R., Anker, S. D. and Cleland, J. G.F. (2017) Non-invasive measurement of right atrial pressure by near-infrared spectroscopy: preliminary experience. A report from the SICA-HF study. European Journal of Heart Failure, 19(7), pp. 883-892. (doi: 10.1002/ejhf.825) (PMID:28387033)

Sze, S., Zhang, J., Pellicori, P. , Morgan, D., Hoye, A. and Clark, A.L. (2017) Prognostic value of simple frailty and malnutrition screening tools in patients with acute heart failure due to left ventricular systolic dysfunction. Clinical Research in Cardiology, 106(7), pp. 533-541. (doi: 10.1007/s00392-017-1082-5) (PMID:28204965)

Pellicori, P. , Urbinati, A., Shah, P., MacNamara, A., Kazmi, S., Dierckx, R., Zhang, J., Cleland, J. G.F. and Clark, A. L. (2017) What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan? European Journal of Heart Failure, 19(6), pp. 768-778. (doi: 10.1002/ejhf.788) (PMID:28244205)

Shah, P., Pellicori, P. , Cuthbert, J. and Clark, A. L. (2017) Pharmacological and non-pharmacological treatment for decompensated heart failure: what is new? Current Heart Failure Reports, 14(3), pp. 147-157. (doi: 10.1007/s11897-017-0328-x) (PMID:28421408) (PMCID:PMC5423987)

McDiarmid, A. K., Pellicori, P. , Cleland, J. G.F. and Plein, S. (2017) Taxonomy of segmental myocardial systolic dysfunction. European Heart Journal, 38(13), pp. 942-954. (doi: 10.1093/eurheartj/ehw140) (PMID:27147609) (PMCID:PMC5381597)

Urbinati, A., Pellicori, P. , Guerra, F., Capucci, A. and Clark, A. L. (2017) Takotsubo syndrome in the paediatric population. Journal of Cardiovascular Medicine, 18(4), pp. 262-267. (doi: 10.2459/JCM.0000000000000446) (PMID:27673581)

Dovancescu, S., Pellicori, P. , Mabote, T., Torabi, A., Clark, A. L. and Cleland, J. G.F. (2017) The effects of short-term omission of daily medication on the pathophysiology of heart failure. European Journal of Heart Failure, (doi: 10.1002/ejhf.748) (PMID:28295907)

Cuthbert, J. J., Pellicori, P. , Shah, P. and Clark, A. L. (2017) New pharmacological approaches in heart failure therapy: developments and possibilities. Future Cardiology, 13(2), pp. 173-188. (doi: 10.2217/fca-2016-0068) (PMID:28181443)

Cuthbert, J. J., Pellicori, P. and Clark, A. L. (2017) Interatrial shunt devices for heart failure with normal ejection fraction: a technology update. Medical Devices: Evidence and Research, 10, pp. 123-132. (doi: 10.2147/mder.s113105) (PMID:28652826) (PMCID:PMC5476655)

Pellicori, P. and Carubelli, V. (2017) Terapia diuretica nell’insufficienza cardiaca cronica: evidenze, esperienze, prospettive = Diuretic treatment in patients with chronic heart failure: evidences, experiences, and current perspectives. Giornale Italiano di Cardiologia, 18(2), pp. 129-138. (doi: 10.1714/2663.27298) (PMID:28398366)

Pellicori, P. , Salekin, D., Pan, D. and Clark, A. L. (2017) This patient is not breathing properly: is this COPD, heart failure, or neither? Expert Review of Cardiovascular Therapy, 15(5), pp. 389-396. (doi: 10.1080/14779072.2017.1317592) (PMID:28395556)

2016

Pellicori, P. , Cleland, J. G.F. , Zhang, J., Kallvikbacka-Bennett, A., Urbinati, A., Shah, P., Kazmi, S. and Clark, A. L. (2016) Cardiac dysfunction, congestion and loop diuretics: their relationship to prognosis in heart failure. Cardiovascular Drugs and Therapy, 30(6), pp. 599-609. (doi: 10.1007/s10557-016-6697-7) (PMID:27819111)

Ferreira, J. P. et al. (2016) Renal function estimation and Cockroft–Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: the Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives. BMC Medicine, 14, 181. (doi: 10.1186/s12916-016-0731-2) (PMID:27829460) (PMCID:PMC5103492)

Bekfani, T. et al. (2016) Sarcopenia in patients with heart failure with preserved ejection fraction: impact on muscle strength, exercise capacity and quality of life. International Journal of Cardiology, 222, pp. 41-46. (doi: 10.1016/j.ijcard.2016.07.135) (PMID:27454614)

Cleland, J. G.F. and Pellicori, P. (2016) PARADIGM-HF: does dose matter? European Journal of Heart Failure, 18(10), pp. 1235-1237. (doi: 10.1002/ejhf.634) (PMID:27704710)

Joseph, A. C., Prapa, M., Pellicori, P. , Mabote, T., Nasir, M. and Clark, A. L. (2016) Tachycardia-induced cardiomyopathy in pregnancy. Journal of Cardiovascular Medicine, 17(10), pp. 762-766. (doi: 10.2459/jcm.0000000000000209) (PMID:25486585)

Cleland, J. G.F. , Zhang, J., Pellicori, P. , Dicken, B., Dierckx, R., Shoaib, A., Wong, K., Rigby, A., Goode, K. and Clark, A. L. (2016) Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure. JAMA Cardiology, 1(5), pp. 539-547. (doi: 10.1001/jamacardio.2016.1161) (PMID:27439011)

Pellicori, P. , Goode, K. M., Nicholls, R., Ahmed, D., Clark, A. L. and Cleland, J. G.F. (2016) Regional circulatory distribution of novel cardiac bio-markers and their relationships with haemodynamic measurements. International Journal of Cardiology, 210, pp. 149-155. (doi: 10.1016/j.ijcard.2016.02.081) (PMID:26946041)

Pellicori, P. and Cleland, J.G.F. (2016) New ways to visualize and combat congestion in heart failure = Nuevos modos de visualizar y combatir la congestión en la insuficiencia cardiaca. Revista Clínica Española, 216(4), pp. 202-204. (doi: 10.1016/j.rce.2016.03.007) (PMID:27129360)

Shoaib, A. et al. (2016) Is the diagnostic coding position of acute heart failure related to mortality? A report from the Euro Heart Failure Survey-1. European Journal of Heart Failure, 18(5), pp. 556-563. (doi: 10.1002/ejhf.505) (PMID:26991150)

Koshy, A., Pellicori, P. and Clark, A. L. (2016) The effect of increasing inspired oxygen on exercise performance in patients with chronic heart failure. Heart, 102(8), pp. 597-601. (doi: 10.1136/heartjnl-2015-308932) (PMID:26891754)

Zhang, J., Hobkirk, J., Carroll, S., Pellicori, P. , Clark, A. L. and Cleland, J. G.F. (2016) Exploring quality of life in patients with and without heart failure. International Journal of Cardiology, 202, pp. 676-684. (doi: 10.1016/j.ijcard.2015.09.076) (PMID:26453816)

2015

Pellicori, P. , Joseph, A. C., Zhang, J., Lukaschuk, E., Sherwi, N., Bourantas, C. V., Loh, H., Clark, A. L. and Cleland, J. G.F. (2015) The relationship of QRS morphology with cardiac structure and function in patients with heart failure. Clinical Research in Cardiology, 104(11), pp. 935-945. (doi: 10.1007/s00392-015-0861-0) (PMID:25903113)

Dierckx, R., Cleland, J. G.F. , Pellicori, P. , Zhang, J., Goode, K., Putzu, P., Boyalla, V. and Clark, A. L. (2015) If home telemonitoring reduces mortality in heart failure, is this just due to better guideline-based treatment? Journal of Telemedicine and Telecare, 21(6), pp. 331-339. (doi: 10.1177/1357633X15574947) (PMID:25766855)

Pellicori, P. and Clark, A. L. (2015) Clinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failure. European Journal of Heart Failure, 17(9), pp. 979-983. (doi: 10.1002/ejhf.340) (PMID:26289928)

Pellicori, P. , Kallvikbacka-Bennett, A., Dierckx, R., Zhang, J., Putzu, P., Cuthbert, J., Boyalla, V., Shoaib, A., Clark, A. L. and Cleland, J. G.F. (2015) Prognostic significance of ultrasound-assessed jugular vein distensibility in heart failure. Heart, 101(14), pp. 1149-1158. (doi: 10.1136/heartjnl-2015-307558) (PMID:26006717)

Costanzo, P., Cleland, J. G.F. , Pellicori, P. , Clark, A. L., Hepburn, D., Kilpatrick, E. S., Perrone-Filardi, P., Zhang, J. and Atkin, S. L. (2015) The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Annals of Internal Medicine, 162(9), pp. 610-618. (doi: 10.7326/M14-1551) (PMID:25938991)

Pellicori, P. , Zhang, J., Lukaschuk, E., Joseph, A. C., Bourantas, C. V., Loh, H., Bragadeesh, T., Clark, A. L. and Cleland, J. G.F. (2015) Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value. European Heart Journal, 36(12), pp. 733-742. (doi: 10.1093/eurheartj/ehu405) (PMID:25336215)

Dierckx, R., Cleland, J. G.F. , Parsons, S., Putzu, P., Pellicori, P. , Dicken, B., Boyalla, V. and Clark, A. L. (2015) Prescribing patterns to optimize heart rate: analysis of 1,000 consecutive outpatient appointments to a single heart failure clinic over a 6-month period. JACC: Heart Failure, 3(3), pp. 224-230. (doi: 10.1016/j.jchf.2014.11.003) (PMID:25650369)

Pellicori, P. and Cleland, J. G.F. (2015) Is the epidemic of heart disease really over or just evolving? American Journal of Medicine, 128(3), e17. (doi: 10.1016/j.amjmed.2014.09.018) (PMID:25707889)

Pellicori, P. and Cleland, J. G.F. (2015) Update on management of heart failure with preserved ejection fraction. Current Opinion in Cardiology, 30(2), pp. 173-178. (doi: 10.1097/HCO.0000000000000152) (PMID:25603033)

Boyalla, V., Putzu, P., Dierckx, R., Clark, A. L. and Pellicori, P. (2015) Patent Ductus Arteriosus in older adults: incidental finding or relevant pathology? Journal of the American Geriatrics Society, 63(2), pp. 409-411. (doi: 10.1111/jgs.13256) (PMID:25688625)

Dierckx, R., Pellicori, P. , Cleland, J.G.F. and Clark, A.L. (2015) Telemonitoring in heart failure: Big Brother watching over you. Heart Failure Reviews, 20(1), pp. 107-116. (doi: 10.1007/s10741-014-9449-4) (PMID:24972644)

Pellicori, P. and Costanzo, P. (2015) Betabloccanti in pazienti con scompenso cardiaco e fibrillazione atriale = [Betablockers in patients with heart failure and atrial fibrillation]. Giornale italiano di cardiologia, 16(11), pp. 613-616. (doi: 10.1714/2066.22428) (PMID:26571474)

Pellicori, P. , Kaur, K. and Clark, A. L. (2015) Fluid management in patients with chronic heart failure. Cardiac Failure Review, 1(2), pp. 90-95. (doi: 10.15420/cfr.2015.1.2.90) (PMID:28785439) (PMCID:PMC5490880)

2014

Pellicori, P. and Cleland, J. G.F. (2014) Heart failure with preserved ejection fraction. Clinical Medicine, 14(S6), s22-s28. (doi: 10.7861/clinmedicine.14-6-s22) (PMID:25468914)

Cleland, J. G.F. , Hutchinson, K., Pellicori, P. and Clark, A. (2014) Lipid-modifying treatments for heart failure: is their use justified? Heart Failure Clinics, 10(4), pp. 621-634. (doi: 10.1016/j.hfc.2014.07.006) (PMID:25217437)

Hutchinson, K., Pellicori, P., Dierckx, R., Cleland, J. G.F. and Clark, A. L. (2014) Remote telemonitoring for patients with heart failure: might monitoring pulmonary artery pressure become routine? Expert Review of Cardiovascular Therapy, 12(8), pp. 1025-1033. (doi: 10.1586/14779072.2014.935340) (PMID:24984847)

Cleland, J. G.F. , Pellicori, P. and Dierckx, R. (2014) Clinical trials in patients with heart failure and preserved left ventricular ejection fraction. Heart Failure Clinics, 10(3), pp. 511-523. (doi: 10.1016/j.hfc.2014.04.011) (PMID:24975913)

Goode, K. M., Nicholls, R., Pellicori, P., Clark, A. L. and Cleland, J. G.F. (2014) The in vitro stability of novel cardiovascular and sepsis biomarkers at ambient temperature. Clinical Chemistry and Laboratory Medicine, 52(6), pp. 911-918. (doi: 10.1515/cclm-2013-0767) (PMID:24406281)

Pellicori, P., Kallvikbacka-Bennett, A., Zhang, J., Khaleva, O., Warden, J., Clark, A. L. and Cleland, J. G.F. (2014) Revisiting a classical clinical sign: Jugular venous ultrasound. International Journal of Cardiology, 170(3), pp. 364-370. (doi: 10.1016/j.ijcard.2013.11.015) (PMID:24315339)

Pellicori, P., Kallvikbacka-Bennett, A., Khaleva, O., Carubelli, V., Costanzo, P., Castiello, T., Wong, K., Zhang, J., Cleland, J. G.F. and Clark, A. L. (2014) Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification? International Journal of Cardiovascular Imaging, 30(1), pp. 69-79. (doi: 10.1007/s10554-013-0310-y) (PMID:24150723)

2012

Pellicori, P., Sherwi, N., Khaleva, O., Wong, K. and Cleland, J. G.F. (2012) An atrial mass: the value of echocardiographic three-dimensional reconstruction. Journal of Cardiovascular Medicine, 13(11), pp. 769-770. (doi: 10.2459/JCM.0b013e32834917ed) (PMID:21709575)

This list was generated on Sun May 22 18:55:34 2022 BST.
Jump to: Articles
Number of items: 121.

Articles

Pellicori, P. , McConnachie, A. , Carlin, C., Wales, A. and Cleland, J. G.F. (2022) Predicting mortality after hospitalisation for COPD using electronic health records. Pharmacological Research, 179, 106199. (doi: 10.1016/j.phrs.2022.106199) (PMID:35381341)

Rastogi, T., Bozec, E., Pellicori, P. , Bayes Genis, A., Coiro, S., Domingo, M., Gargani, L., Palazzuoli, A. and Girerd, N. (2022) Prognostic value and therapeutic utility of lung ultrasound in acute and chronic heart failure: a meta-analysis. JACC: Cardiovascular Imaging, 15(5), pp. 950-952. (doi: 10.1016/j.jcmg.2021.11.024) (PMID:35033496)

Verdonschot, J. A.J. et al. (2022) The effect of spironolactone in patients with obesity at risk for heart failure: proteomic insights from the HOMAGE trial. Journal of Cardiac Failure, 28(5), pp. 778-786. (doi: 10.1016/j.cardfail.2021.12.005) (PMID:34933097)

Pellicori, P. and Cleland, J. G. F. (2022) Heart failure: age is no excuse for complacency. European Journal of Heart Failure, (doi: 10.1002/ejhf.2517) (PMID:35481861) (Early Online Publication)

Girerd, N. et al. (2022) Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction. ESC Heart Failure, (doi: 10.1002/ehf2.13929) (PMID:35429120) (Early Online Publication)

Girerd, N. et al. (2022) Practical outpatient management of worsening chronic heart failure. European Journal of Heart Failure, (doi: 10.1002/ejhf.2503) (PMID:35417093) (Early Online Publication)

Rastogi, T. et al. (2022) Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank. European Journal of Heart Failure, (doi: 10.1002/ejhf.2495) (PMID:35365899) (Early Online Publication)

Cleland, J. G.F. , Butler, J., Januzzi, J. L., Pellicori, P. and McDonagh, T. (2022) Only people with increased plasma concentrations of natriuretic peptides should be included in outcome trials of diabetes, cardiovascular and kidney disease: implications for clinical practice. European Journal of Heart Failure, 24(4), pp. 678-680. (doi: 10.1002/ejhf.2488) (PMID:35297132)

Ferreira, J. P. et al. (2022) Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial. European Heart Journal: Cardiovascular Pharmacotherapy, 8(2), pp. 149-156. (doi: 10.1093/ehjcvp/pvab031) (PMID:33822033)

Pellicori, P. , Vaduganathan, M., Ferreira, J. P., Zannad, F. and Sanyal, A. J. (2022) Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design. Diabetes and Metabolism, 48(2), 101281. (doi: 10.1016/j.diabet.2021.101281) (PMID:34543735)

Ferreira, J. P. et al. (2022) Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial. European Journal of Heart Failure, (doi: 10.1002/ejhf.2455) (PMID:35199421) (Early Online Publication)

Masini, G., Graham, F. J., Pellicori, P. , Cleland, J. G.F. , Cuthbert, J. J., Kazmi, S., Inciardi, R. M. and Clark, A. L. (2022) Criteria for iron deficiency in patients with heart failure. Journal of the American College of Cardiology, 79(4), pp. 341-351. (doi: 10.1016/j.jacc.2021.11.039) (PMID:35086656)

Caiazzo, E., Rezig, A. O.M. , Bruzzese, D., Ialenti, A., Cicala, C., Cleland, J. G.F. , Guzik, T. J., Maffia, P. and Pellicori, P. (2022) Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: a systematic review and meta-analysis of randomised trials. Pharmacological Research, 176, 106053. (doi: 10.1016/j.phrs.2021.106053) (PMID:34979235) (PMCID:PMC8719379)

Ravassa, S. et al. (2022) Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial. European Journal of Heart Failure, 24(2), pp. 321-331. (doi: 10.1002/ejhf.2394) (PMID:34841615)

Mesin, L. et al. (2022) Assessment of phasic changes of vascular size by automated edge tracking-state of the art and clinical perspectives. Frontiers in Cardiovascular Medicine, 8, 775635. (doi: 10.3389/fcvm.2021.775635) (PMID:35127855) (PMCID:PMC8814097)

Cuthbert, J.J. et al. (2022) Hypochloraemia following admission to hospital with heart failure is common and associated with an increased risk of readmission or death: a report from OPERA-HF. European Heart Journal: Acute Cardiovascular Care, 11(1), pp. 43-52. (doi: 10.1093/ehjacc/zuab097) (PMID:34897402)

Ferreira, J. P., Girerd, N., Rocca, H.-P. B.-L., Pellicori, P. , Cleland, J. G. , Rossignol, P. and Zannad, F. (2021) No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial = Pas d’influence de la spironolactone sur les concentrations plasmatiques de l’enzyme de conversion de l’angiotensine 2 : résultats de l’essai randomisé HOMAGE. Archives of Cardiovascular Diseases, 114(12), pp. 814-817. (doi: 10.1016/j.acvd.2021.10.003) (PMID:34772647) (PMCID:PMC8576594)

Cuthbert, J. J., Pellicori, P. , Flockton, R., Kallvikbacka-Bennett, A., Khan, J., Rigby, A. S., Girerd, N., Zannad, F., Cleland, J. G.F. and Clark, A. L. (2021) The prevalence and clinical associations of ultrasound measures of congestion in patients at risk of developing heart failure. European Journal of Heart Failure, 23(11), pp. 1831-1840. (doi: 10.1002/ejhf.2353) (PMID:34632680)

Pan, D. et al. (2021) Prognostic value of the chest x-ray in patients hospitalised for heart failure. Clinical Research in Cardiology, 110(11), pp. 1743-1756. (doi: 10.1007/s00392-021-01836-9) (PMID:33754159)

Anderson, J. J. et al. (2021) Remote history of VTE is associated with severe COVID-19 in middle and older age: UK Biobank cohort study. Journal of Thrombosis and Haemostasis, 19(10), pp. 2533-2538. (doi: 10.1111/jth.15452) (PMID:34242477) (PMCID:PMC8420476)

Graham, F. J., Pellicori, P. , Cleland, J. G.F. and Clark, A. L. (2021) Reply to the letter regarding the article 'Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure'. European Journal of Heart Failure, 23(10), pp. 1800-1801. (doi: 10.1002/ejhf.2304) (PMID:34263510)

Shah, P., Abel, A. A.I., Boyalla, V., Pellicori, P. , Kallvikbacka-Bennett, A., Sze, S., Cleland, J. G.F. and Clark, A. L. (2021) A comparison of non-invasive methods of measuring body composition in patients with heart failure: a report from SICA-HF. ESC Heart Failure, 8(5), pp. 3929-3934. (doi: 10.1002/ehf2.13402) (PMID:34216106) (PMCID:PMC8497207)

Cleland, J. G.F. and Pellicori, P. (2021) To master heart failure, first master congestion. Lancet, 398(10304), pp. 935-936. (doi: 10.1016/S0140-6736(21)01914-0) (PMID:34461039)

Pellicori, P. and Cleland, J. G.F. (2021) Structural heart disease, cardiac dysfunction and heart failure: the ambiguity of a definition. European Journal of Preventive Cardiology, 28(9), pp. 921-923. (doi: 10.1177/2047487320937135) (PMID:32718235)

Verdonschot, J. A.J. et al. (2021) Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial. Cardiovascular Diabetology, 20, 163. (doi: 10.1186/s12933-021-01357-9)

Castrichini, M., Nuzzi, V., Sinagra, G., Cleland, J. and Pellicori, P. (2021) Use of social media by cardiovascular health care professionals: is patient privacy respected? JACC: Cardiovascular Imaging, 14(8), pp. 1680-1682. (doi: 10.1016/j.jcmg.2021.02.012) (PMID:34023252)

Cleland, J. G.F. , Pellicori, P. and González, A. (2021) A novel treatment for heart failure targets myocardial fibrosis. Nature Medicine, 27(8), pp. 1343-1344. (doi: 10.1038/s41591-021-01457-9) (PMID:34385705)

Graham, F. J., Pellicori, P. , Ford, I. , Petrie, M. C. , Kalra, P. R. and Cleland, J. G.F. (2021) Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials. Clinical Research in Cardiology, 110(8), pp. 1299-1307. (doi: 10.1007/s00392-021-01837-8) (PMID:33755777)

Kobayashi, M. et al. (2021) Association between right-sided cardiac function and ultrasound-based pulmonary congestion on acutely decompensated heart failure findings from a pooled analysis of four cohort studies. Clinical Research in Cardiology, 110(8), pp. 1181-1192. (doi: 10.1007/s00392-020-01724-8) (PMID:32770373)

Pellicori, P. et al. (2021) Use of diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA-REG OUTCOME trial. European Journal of Heart Failure, 23(7), pp. 1085-1093. (doi: 10.1002/ejhf.2220) (PMID:34031968)

Cleland, J. G.F. et al. (2021) The struggle towards a universal definition of heart failure—how to proceed? European Heart Journal, 42(24), pp. 2331-2343. (doi: 10.1093/eurheartj/ehab082) (PMID:33791787)

Pandhi, P. et al. (2021) The value of spot urinary creatinine as a marker of muscle wasting in patients with new-onset or worsening heart failure. Journal of Cachexia, Sarcopenia and Muscle, 12(3), pp. 555-567. (doi: 10.1002/jcsm.12690) (PMID:33742549)

Graham, F. J., Masini, G., Pellicori, P. , Cleland, J. G.F. , Greenlaw, N., Friday, J., Kazmi, S. and Clark, A. L. (2021) Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure. European Journal of Heart Failure, (doi: 10.1002/ejhf.2251) (PMID:34050582) (Early Online Publication)

Pellicori, P. et al. (2021) Ultrasound imaging of congestion in heart failure – examinations beyond the heart. European Journal of Heart Failure, 23(5), pp. 703-712. (doi: 10.1002/ejhf.2032) (PMID:33118672)

Zhang, J., Pellicori, P. , Schutte, R. and Cleland, J.G. (2021) The association between blood groups and COVID-19 infection: a study from the UK Biobank. Journal of Internal Medicine, 289(5), pp. 747-748. (doi: 10.1111/joim.13226) (PMID:33306225)

Ferreira, J. P. et al. (2021) Proteomic and mechanistic analysis of spironolactone in patients at risk for HF. JACC: Heart Failure, 9(4), pp. 268-277. (doi: 10.1016/j.jchf.2020.11.010) (PMID:33549556)

Pellicori, P. et al. (2021) COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database of Systematic Reviews, 2021(3), CD013879. (doi: 10.1002/14651858.CD013879) (PMID:33704775)

Sze, S., Pellicori, P. , Zhang, J., Weston, J. and Clark, A. L. (2021) The impact of malnutrition on short-term morbidity and mortality in ambulatory patients with heart failure. American Journal of Clinical Nutrition, 113(3), pp. 695-705. (doi: 10.1093/ajcn/nqaa311) (PMID:33236050)

Cleland, J. G.F. et al. (2021) The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial. European Heart Journal, 42(6), pp. 684-696. (doi: 10.1093/eurheartj/ehaa758) (PMID:33215209) (PMCID:PMC7878013)

Anderson, J. J. et al. (2021) Ethnic differences in prevalence of actionable HbA1c levels in UK Biobank: implications for screening. BMJ Open Diabetes Research and Care, 9(1), e002176. (doi: 10.1136/bmjdrc-2021-002176) (PMID:34353880) (PMCID:PMC8344314)

Shah, P., Pellicori, P. , Hanning, I., Zhang, J., Clark, A. L. and Bhandari, S. (2021) The effect of digoxin on renal function in patients with heart failure. BMC Nephrology, 22(1), 349. (doi: 10.1186/s12882-021-02562-0) (PMCID:PMC8549227)

Pellicori, P. , Ofstad, A. P., Fitchett, D., Zeller, C., Wanner, C., George, J., Zinman, B., Brueckmann, M. and Lindenfeld, J. (2020) Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA-REG OUTCOME. ESC Heart Failure, 7(6), pp. 3401-3407. (doi: 10.1002/ehf2.12891) (PMID:32915523) (PMCID:PMC7754994)

Palazzuoli, A., Ruocco, G., Franci, B., Evangelista, I., Lucani, B., Nuti, R. and Pellicori, P. (2020) Ultrasound indices of congestion in patients with acute heart failure according to body mass index. Clinical Research in Cardiology, 109(11), pp. 1423-1433. (doi: 10.1007/s00392-020-01642-9) (PMID:32296972)

Pellicori, P. et al. (2020) Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial. European Journal of Heart Failure, 22(9), pp. 1711-1723. (doi: 10.1002/ejhf.1716) (PMID:31950604)

Voors, A. A. et al. (2020) Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial. European Journal of Heart Failure, 22(9), pp. 1649-1658. (doi: 10.1002/ejhf.1933) (PMID:32558989) (PMCID:PMC7689751)

Pan, D., Pellicori, P. , Walklett, C., Green, A., Masse, A. R., Wood, J., Purdy, J. and Clark, A. L. (2020) Driving habits and reaction times on a driving simulation in older drivers with chronic heart failure. Journal of Cardiac Failure, 26(7), pp. 555-563. (doi: 10.1016/j.cardfail.2020.04.002) (PMID:32433933)

Cleland, J. G.F. , Clark, R. A., Pellicori, P. and Inglis, S. C. (2020) Caring for people with heart failure and many other medical problems through and beyond the COVID‐19 pandemic; the advantages of universal‐access to home telemonitoring. European Journal of Heart Failure, 22(6), pp. 995-998. (doi: 10.1002/ejhf.1864) (PMID:32385954) (PMCID:PMC7273055)

Sze, S., Pellicori, P. , Zhang, J., Weston, J. and Clark, A. (2020) Agreement and classification performance of malnutrition tools in patients with chronic heart failure. Current Developments in Nutrition, 4(6), nzaa071. (doi: 10.1093/cdn/nzaa071) (PMID:32529169) (PMCID:PMC7272189)

Pellicori, P. (2020) At the heart of COVID-19. European Heart Journal, 41(19), pp. 1830-1832. (doi: 10.1093/eurheartj/ehaa415) (PMID:32405639)

Hayes, S. et al. (2020) Association between walking pace and stroke incidence: findings from the UK Biobank prospective cohort study. Stroke, 51(5), pp. 1388-1395. (doi: 10.1161/STROKEAHA.119.028064) (PMID:32299326)

Stienen, S., Ferreira, J. P., Pitt, B., Cleland, J. G. , Pellicori, P. , Girerd, N., Rossignol, P. and Zannad, F. (2020) Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure. European Journal of Heart Failure, 22(5), pp. 901-903. (doi: 10.1002/ejhf.1812) (PMID:32243646)

Pellicori, P. , Cleland, J. G.F. and Clark, A. L. (2020) Chronic obstructive pulmonary disease and heart failure: a breathless conspiracy. Heart Failure Clinics, 16(1), pp. 33-44. (doi: 10.1016/j.hfc.2019.08.003) (PMID:31735313)

Pellicori, P. , Khan, M. J. I., Graham, F. J. and Cleland, J. G.F. (2020) New perspectives and future directions in the treatment of heart failure. Heart Failure Reviews, 25, pp. 147-159. (doi: 10.1007/s10741-019-09829-7) (PMID:31327116) (PMCID:PMC6985084)

Pellicori, P. , Zhang, J., Cuthbert, J., Urbinati, A., Shah, P., Kazmi, S., Clark, A. L. and Cleland, J. G.F. (2020) High sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death. Cardiovascular Research, 116(1), pp. 91-100. (doi: 10.1093/cvr/cvz198) (PMID:31350553)

Pellicori, P. , Urbinati, A., Kaur, K., Zhang, J., Shah, P., Kazmi, S., Capucci, A., Cleland, J. G.F. and Clark, A. L. (2019) Prevalence and incidence of atrial fibrillation in ambulatory patients with heart failure. American Journal of Cardiology, 124(10), pp. 1554-1560. (doi: 10.1016/j.amjcard.2019.08.018) (PMID:31558271)

Sillars, A. et al. (2019) Association of fitness and grip-strength with heart failure: findings from the UK Biobank population-based study. Mayo Clinic Proceedings, 94(11), pp. 2230-2240. (doi: 10.1016/j.mayocp.2019.04.041) (PMID:31685151)

Cleland, J. G.F. and Pellicori, P. (2019) Myocardial dysfunction and coronary artery disease as therapeutic targets in heart failure. Circulation, 140(7), pp. 538-541. (doi: 10.1161/CIRCULATIONAHA.119.041523) (PMID:31403847)

Nuzzi, V. et al. (2019) Clinical and prognostic association of total atrial conduction time in patients with heart failure: a report from Studies Investigating Co-morbidities Aggravating Heart Failure. Journal of Cardiovascular Medicine, 20(7), pp. 442-449. (doi: 10.2459/JCM.0000000000000802) (PMID:30985354)

Pellicori, P. , Shah, P., Cuthbert, J., Urbinati, A., Zhang, J., Kallvikbacka-Bennett, A., Clark, A. L. and Cleland, J. G.F. (2019) Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure. European Journal of Heart Failure, 21(7), pp. 904-916. (doi: 10.1002/ejhf.1383) (PMID:30666769)

Cleland, J. G.F. , Pellicori, P. and Clark, A. L. (2019) Prevention or procrastination for heart failure?: Why we need a universal definition of heart failure. Journal of the American College of Cardiology, 73(19), pp. 2398-2400. (doi: 10.1016/j.jacc.2019.03.471) (PMID:31097158)

Shah, P., Pellicori, P. , Kallvikbacka-Bennett, A., Zhang, J., Pan, D. and Clark, A. L. (2019) Warm water immersion in patients with chronic heart failure: a pilot study. Clinical Research in Cardiology, 108(5), pp. 468-476. (doi: 10.1007/s00392-018-1376-2) (PMID:30267153) (PMCID:PMC6484774)

Sze, S., Pellicori, P. , Zhang, J., Weston, J. and Clark, A. L. (2019) Identification of frailty in chronic heart failure. JACC: Heart Failure, 7(4), pp. 291-302. (doi: 10.1016/j.jchf.2018.11.017) (PMID:30738977)

Celis-Morales, C. A. et al. (2019) Walking pace is associated with lower risk of all-cause and cause-specific mortality. Medicine and Science in Sports and Exercise, 51(3), pp. 472-480. (doi: 10.1249/MSS.0000000000001795) (PMID:30303933)

Palazzuoli, A., Ruocco, G., Pellicori, P. , Incampo, E., Di Tommaso, C., Favilli, R., Evangelista, I., Nuti, R. and Testani, J. M. (2019) The prognostic role of different renal function phenotypes in patients with acute heart failure. International Journal of Cardiology, 276, pp. 198-203. (doi: 10.1016/j.ijcard.2018.11.108) (PMID:30503187)

Bekfani, T. et al. (2019) Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life. Clinical Research in Cardiology, 108(2), pp. 203-211. (doi: 10.1007/s00392-018-1344-x) (PMID:30051186)

Sze, S., Pellicori, P. , Zhang, J. and Clark, A. L. (2019) Malnutrition, congestion and mortality in ambulatory patients with heart failure. Heart, 105(4), pp. 297-306. (doi: 10.1136/heartjnl-2018-313312) (PMID:30121635)

Zhang, J., Begley, A., Jackson, R., Harrison, M., Pellicori, P. , Clark, A. L. and Cleland, J. G.F. (2019) Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose–response meta-analysis. Clinical Research in Cardiology, 108(2), pp. 119-132. (doi: 10.1007/s00392-018-1302-7) (PMID:29951802)

Zhang, J., Pellicori, P. , Pan, D., Dierckx, R., Clark, A.L. and Cleland, J.G.F. (2018) Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure. International Journal of Cardiology, 269, pp. 196-200. (doi: 10.1016/j.ijcard.2018.06.070) (PMID:30001941)

Shah, P., Pellicori, P. , Rimmer, S., Rigby, A. S. and Clark, A. L. (2018) Effect of increased inspired oxygen on exercise performance in patients with heart failure and normal ejection fraction. International Journal of Cardiology, 268, pp. 166-169. (doi: 10.1016/j.ijcard.2018.05.029) (PMID:29803343)

Cuthbert, J. J., Pellicori, P. , Rigby, A., Pan, D., Kazmi, S., Shah, P. and Clark, A. L. (2018) Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance. European Journal of Heart Failure, 20(10), pp. 1426-1435. (doi: 10.1002/ejhf.1247) (PMID:29943886)

Sze, S., Pellicori, P. , Kamzi, S., Anton, A. and Clark, A. L. (2018) Effect of beta-adrenergic blockade on weight changes in patients with chronic heart failure. International Journal of Cardiology, 264, pp. 104-112. (doi: 10.1016/j.ijcard.2018.03.089) (PMID:29628277)

Pellicori, P. , Cleland, J. G.F. and Clark, A. L. (2018) Losing track by tracking speckles. JACC: Cardiovascular Imaging, 11(7), pp. 1038-1039. (doi: 10.1016/j.jcmg.2018.04.027) (PMID:29976301)

Sze, S., Pellicori, P. , Kazmi, S., Rigby, A., Cleland, J. G.F. , Wong, K. and Clark, A. L. (2018) Prevalence and prognostic significance of malnutrition using 3 scoring systems among outpatients with heart failure: a comparison with body mass index. JACC: Heart Failure, 6(6), pp. 476-486. (doi: 10.1016/j.jchf.2018.02.018) (PMID:29753673)

Sokoreli, I., Pauws, S. C., Steyerberg, E. W., de Vries, G.-J., Riistama, J. M., Tesanovic, A., Kazmi, S., Pellicori, P. , Cleland, J. G. and Clark, A. L. (2018) Prognostic value of psychosocial factors for first and recurrent hospitalizations and mortality in heart failure patients: insights from the OPERA-HF study. European Journal of Heart Failure, 20(4), pp. 689-696. (doi: 10.1002/ejhf.1112) (PMID:29314447)

Nikolaidou, T., Pellicori, P. , Zhang, J., Kazmi, S., Goode, K. M., Cleland, J. G. and Clark, A. L. (2018) Prevalence, predictors, and prognostic implications of PR interval prolongation in patients with heart failure. Clinical Research in Cardiology, 107(2), pp. 108-119. (doi: 10.1007/s00392-017-1162-6) (PMID:28917011) (PMCID:PMC5790844)

Pellicori, P. , Urbinati, A., Zhang, J., Joseph, A. C., Costanzo, P., Lukaschuk, E., Capucci, A., Cleland, J. G.F. and Clark, A. L. (2018) Clinical and prognostic relationships of pulmonary artery to aorta diameter ratio in patients with heart failure: a cardiac magnetic resonance imaging study. Clinical Cardiology, 41(1), pp. 20-27. (doi: 10.1002/clc.22840) (PMID:29359813))

Shah, P., Pellicori, P. , Macnamara, A., Urbinati, A. and Clark, A. L. (2017) Is swimming safe in heart failure? A systematic review. Cardiology in Review, 25(6), pp. 321-325. (doi: 10.1097/CRD.0000000000000154) (PMID:28767502)

Cleland, J. G.F. , Pellicori, P. , Clark, A. L. and Petrie, M. C. (2017) Time to take the failure out of heart failure: the importance of optimism. JACC: Heart Failure, 5(7), pp. 538-540. (doi: 10.1016/j.jchf.2017.04.003) (PMID:28624485)

Pellicori, P. , Clark, A. L., Kallvikbacka-Bennett, A., Zhang, J., Urbinati, A., Monzo, L., Dierckx, R., Anker, S. D. and Cleland, J. G.F. (2017) Non-invasive measurement of right atrial pressure by near-infrared spectroscopy: preliminary experience. A report from the SICA-HF study. European Journal of Heart Failure, 19(7), pp. 883-892. (doi: 10.1002/ejhf.825) (PMID:28387033)

Sze, S., Zhang, J., Pellicori, P. , Morgan, D., Hoye, A. and Clark, A.L. (2017) Prognostic value of simple frailty and malnutrition screening tools in patients with acute heart failure due to left ventricular systolic dysfunction. Clinical Research in Cardiology, 106(7), pp. 533-541. (doi: 10.1007/s00392-017-1082-5) (PMID:28204965)

Pellicori, P. , Urbinati, A., Shah, P., MacNamara, A., Kazmi, S., Dierckx, R., Zhang, J., Cleland, J. G.F. and Clark, A. L. (2017) What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan? European Journal of Heart Failure, 19(6), pp. 768-778. (doi: 10.1002/ejhf.788) (PMID:28244205)

Shah, P., Pellicori, P. , Cuthbert, J. and Clark, A. L. (2017) Pharmacological and non-pharmacological treatment for decompensated heart failure: what is new? Current Heart Failure Reports, 14(3), pp. 147-157. (doi: 10.1007/s11897-017-0328-x) (PMID:28421408) (PMCID:PMC5423987)

McDiarmid, A. K., Pellicori, P. , Cleland, J. G.F. and Plein, S. (2017) Taxonomy of segmental myocardial systolic dysfunction. European Heart Journal, 38(13), pp. 942-954. (doi: 10.1093/eurheartj/ehw140) (PMID:27147609) (PMCID:PMC5381597)

Urbinati, A., Pellicori, P. , Guerra, F., Capucci, A. and Clark, A. L. (2017) Takotsubo syndrome in the paediatric population. Journal of Cardiovascular Medicine, 18(4), pp. 262-267. (doi: 10.2459/JCM.0000000000000446) (PMID:27673581)

Dovancescu, S., Pellicori, P. , Mabote, T., Torabi, A., Clark, A. L. and Cleland, J. G.F. (2017) The effects of short-term omission of daily medication on the pathophysiology of heart failure. European Journal of Heart Failure, (doi: 10.1002/ejhf.748) (PMID:28295907)

Cuthbert, J. J., Pellicori, P. , Shah, P. and Clark, A. L. (2017) New pharmacological approaches in heart failure therapy: developments and possibilities. Future Cardiology, 13(2), pp. 173-188. (doi: 10.2217/fca-2016-0068) (PMID:28181443)

Cuthbert, J. J., Pellicori, P. and Clark, A. L. (2017) Interatrial shunt devices for heart failure with normal ejection fraction: a technology update. Medical Devices: Evidence and Research, 10, pp. 123-132. (doi: 10.2147/mder.s113105) (PMID:28652826) (PMCID:PMC5476655)

Pellicori, P. and Carubelli, V. (2017) Terapia diuretica nell’insufficienza cardiaca cronica: evidenze, esperienze, prospettive = Diuretic treatment in patients with chronic heart failure: evidences, experiences, and current perspectives. Giornale Italiano di Cardiologia, 18(2), pp. 129-138. (doi: 10.1714/2663.27298) (PMID:28398366)

Pellicori, P. , Salekin, D., Pan, D. and Clark, A. L. (2017) This patient is not breathing properly: is this COPD, heart failure, or neither? Expert Review of Cardiovascular Therapy, 15(5), pp. 389-396. (doi: 10.1080/14779072.2017.1317592) (PMID:28395556)

Pellicori, P. , Cleland, J. G.F. , Zhang, J., Kallvikbacka-Bennett, A., Urbinati, A., Shah, P., Kazmi, S. and Clark, A. L. (2016) Cardiac dysfunction, congestion and loop diuretics: their relationship to prognosis in heart failure. Cardiovascular Drugs and Therapy, 30(6), pp. 599-609. (doi: 10.1007/s10557-016-6697-7) (PMID:27819111)

Ferreira, J. P. et al. (2016) Renal function estimation and Cockroft–Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: the Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives. BMC Medicine, 14, 181. (doi: 10.1186/s12916-016-0731-2) (PMID:27829460) (PMCID:PMC5103492)

Bekfani, T. et al. (2016) Sarcopenia in patients with heart failure with preserved ejection fraction: impact on muscle strength, exercise capacity and quality of life. International Journal of Cardiology, 222, pp. 41-46. (doi: 10.1016/j.ijcard.2016.07.135) (PMID:27454614)

Cleland, J. G.F. and Pellicori, P. (2016) PARADIGM-HF: does dose matter? European Journal of Heart Failure, 18(10), pp. 1235-1237. (doi: 10.1002/ejhf.634) (PMID:27704710)

Joseph, A. C., Prapa, M., Pellicori, P. , Mabote, T., Nasir, M. and Clark, A. L. (2016) Tachycardia-induced cardiomyopathy in pregnancy. Journal of Cardiovascular Medicine, 17(10), pp. 762-766. (doi: 10.2459/jcm.0000000000000209) (PMID:25486585)

Cleland, J. G.F. , Zhang, J., Pellicori, P. , Dicken, B., Dierckx, R., Shoaib, A., Wong, K., Rigby, A., Goode, K. and Clark, A. L. (2016) Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure. JAMA Cardiology, 1(5), pp. 539-547. (doi: 10.1001/jamacardio.2016.1161) (PMID:27439011)

Pellicori, P. , Goode, K. M., Nicholls, R., Ahmed, D., Clark, A. L. and Cleland, J. G.F. (2016) Regional circulatory distribution of novel cardiac bio-markers and their relationships with haemodynamic measurements. International Journal of Cardiology, 210, pp. 149-155. (doi: 10.1016/j.ijcard.2016.02.081) (PMID:26946041)

Pellicori, P. and Cleland, J.G.F. (2016) New ways to visualize and combat congestion in heart failure = Nuevos modos de visualizar y combatir la congestión en la insuficiencia cardiaca. Revista Clínica Española, 216(4), pp. 202-204. (doi: 10.1016/j.rce.2016.03.007) (PMID:27129360)

Shoaib, A. et al. (2016) Is the diagnostic coding position of acute heart failure related to mortality? A report from the Euro Heart Failure Survey-1. European Journal of Heart Failure, 18(5), pp. 556-563. (doi: 10.1002/ejhf.505) (PMID:26991150)

Koshy, A., Pellicori, P. and Clark, A. L. (2016) The effect of increasing inspired oxygen on exercise performance in patients with chronic heart failure. Heart, 102(8), pp. 597-601. (doi: 10.1136/heartjnl-2015-308932) (PMID:26891754)

Zhang, J., Hobkirk, J., Carroll, S., Pellicori, P. , Clark, A. L. and Cleland, J. G.F. (2016) Exploring quality of life in patients with and without heart failure. International Journal of Cardiology, 202, pp. 676-684. (doi: 10.1016/j.ijcard.2015.09.076) (PMID:26453816)

Pellicori, P. , Joseph, A. C., Zhang, J., Lukaschuk, E., Sherwi, N., Bourantas, C. V., Loh, H., Clark, A. L. and Cleland, J. G.F. (2015) The relationship of QRS morphology with cardiac structure and function in patients with heart failure. Clinical Research in Cardiology, 104(11), pp. 935-945. (doi: 10.1007/s00392-015-0861-0) (PMID:25903113)

Dierckx, R., Cleland, J. G.F. , Pellicori, P. , Zhang, J., Goode, K., Putzu, P., Boyalla, V. and Clark, A. L. (2015) If home telemonitoring reduces mortality in heart failure, is this just due to better guideline-based treatment? Journal of Telemedicine and Telecare, 21(6), pp. 331-339. (doi: 10.1177/1357633X15574947) (PMID:25766855)

Pellicori, P. and Clark, A. L. (2015) Clinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failure. European Journal of Heart Failure, 17(9), pp. 979-983. (doi: 10.1002/ejhf.340) (PMID:26289928)

Pellicori, P. , Kallvikbacka-Bennett, A., Dierckx, R., Zhang, J., Putzu, P., Cuthbert, J., Boyalla, V., Shoaib, A., Clark, A. L. and Cleland, J. G.F. (2015) Prognostic significance of ultrasound-assessed jugular vein distensibility in heart failure. Heart, 101(14), pp. 1149-1158. (doi: 10.1136/heartjnl-2015-307558) (PMID:26006717)

Costanzo, P., Cleland, J. G.F. , Pellicori, P. , Clark, A. L., Hepburn, D., Kilpatrick, E. S., Perrone-Filardi, P., Zhang, J. and Atkin, S. L. (2015) The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Annals of Internal Medicine, 162(9), pp. 610-618. (doi: 10.7326/M14-1551) (PMID:25938991)

Pellicori, P. , Zhang, J., Lukaschuk, E., Joseph, A. C., Bourantas, C. V., Loh, H., Bragadeesh, T., Clark, A. L. and Cleland, J. G.F. (2015) Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value. European Heart Journal, 36(12), pp. 733-742. (doi: 10.1093/eurheartj/ehu405) (PMID:25336215)

Dierckx, R., Cleland, J. G.F. , Parsons, S., Putzu, P., Pellicori, P. , Dicken, B., Boyalla, V. and Clark, A. L. (2015) Prescribing patterns to optimize heart rate: analysis of 1,000 consecutive outpatient appointments to a single heart failure clinic over a 6-month period. JACC: Heart Failure, 3(3), pp. 224-230. (doi: 10.1016/j.jchf.2014.11.003) (PMID:25650369)

Pellicori, P. and Cleland, J. G.F. (2015) Is the epidemic of heart disease really over or just evolving? American Journal of Medicine, 128(3), e17. (doi: 10.1016/j.amjmed.2014.09.018) (PMID:25707889)

Pellicori, P. and Cleland, J. G.F. (2015) Update on management of heart failure with preserved ejection fraction. Current Opinion in Cardiology, 30(2), pp. 173-178. (doi: 10.1097/HCO.0000000000000152) (PMID:25603033)

Boyalla, V., Putzu, P., Dierckx, R., Clark, A. L. and Pellicori, P. (2015) Patent Ductus Arteriosus in older adults: incidental finding or relevant pathology? Journal of the American Geriatrics Society, 63(2), pp. 409-411. (doi: 10.1111/jgs.13256) (PMID:25688625)

Dierckx, R., Pellicori, P. , Cleland, J.G.F. and Clark, A.L. (2015) Telemonitoring in heart failure: Big Brother watching over you. Heart Failure Reviews, 20(1), pp. 107-116. (doi: 10.1007/s10741-014-9449-4) (PMID:24972644)

Pellicori, P. and Costanzo, P. (2015) Betabloccanti in pazienti con scompenso cardiaco e fibrillazione atriale = [Betablockers in patients with heart failure and atrial fibrillation]. Giornale italiano di cardiologia, 16(11), pp. 613-616. (doi: 10.1714/2066.22428) (PMID:26571474)

Pellicori, P. , Kaur, K. and Clark, A. L. (2015) Fluid management in patients with chronic heart failure. Cardiac Failure Review, 1(2), pp. 90-95. (doi: 10.15420/cfr.2015.1.2.90) (PMID:28785439) (PMCID:PMC5490880)

Pellicori, P. and Cleland, J. G.F. (2014) Heart failure with preserved ejection fraction. Clinical Medicine, 14(S6), s22-s28. (doi: 10.7861/clinmedicine.14-6-s22) (PMID:25468914)

Cleland, J. G.F. , Hutchinson, K., Pellicori, P. and Clark, A. (2014) Lipid-modifying treatments for heart failure: is their use justified? Heart Failure Clinics, 10(4), pp. 621-634. (doi: 10.1016/j.hfc.2014.07.006) (PMID:25217437)

Hutchinson, K., Pellicori, P., Dierckx, R., Cleland, J. G.F. and Clark, A. L. (2014) Remote telemonitoring for patients with heart failure: might monitoring pulmonary artery pressure become routine? Expert Review of Cardiovascular Therapy, 12(8), pp. 1025-1033. (doi: 10.1586/14779072.2014.935340) (PMID:24984847)

Cleland, J. G.F. , Pellicori, P. and Dierckx, R. (2014) Clinical trials in patients with heart failure and preserved left ventricular ejection fraction. Heart Failure Clinics, 10(3), pp. 511-523. (doi: 10.1016/j.hfc.2014.04.011) (PMID:24975913)

Goode, K. M., Nicholls, R., Pellicori, P., Clark, A. L. and Cleland, J. G.F. (2014) The in vitro stability of novel cardiovascular and sepsis biomarkers at ambient temperature. Clinical Chemistry and Laboratory Medicine, 52(6), pp. 911-918. (doi: 10.1515/cclm-2013-0767) (PMID:24406281)

Pellicori, P., Kallvikbacka-Bennett, A., Zhang, J., Khaleva, O., Warden, J., Clark, A. L. and Cleland, J. G.F. (2014) Revisiting a classical clinical sign: Jugular venous ultrasound. International Journal of Cardiology, 170(3), pp. 364-370. (doi: 10.1016/j.ijcard.2013.11.015) (PMID:24315339)

Pellicori, P., Kallvikbacka-Bennett, A., Khaleva, O., Carubelli, V., Costanzo, P., Castiello, T., Wong, K., Zhang, J., Cleland, J. G.F. and Clark, A. L. (2014) Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification? International Journal of Cardiovascular Imaging, 30(1), pp. 69-79. (doi: 10.1007/s10554-013-0310-y) (PMID:24150723)

Pellicori, P., Sherwi, N., Khaleva, O., Wong, K. and Cleland, J. G.F. (2012) An atrial mass: the value of echocardiographic three-dimensional reconstruction. Journal of Cardiovascular Medicine, 13(11), pp. 769-770. (doi: 10.2459/JCM.0b013e32834917ed) (PMID:21709575)

This list was generated on Sun May 22 18:55:34 2022 BST.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Iron deficiency and cardiac surgery
    British Heart Foundation
    2021 - 2024
     
  • The epidemiology and clinical relevance of pre-clinical congestion quantified by natriuretic peptides and novel ultrasound methods in patients at risk of developing heart failure
    Heart Research UK
    2019 - 2022
     

Supervision

Research datasets

Jump to: 2022
Number of items: 1.

2022

Cester, L., Starshynov, I. , Jones, Y., Pellicori, P. , Cleland, J. and Faccio, D. (2022) Remote laser-speckle sensing of heart sounds for health assessment and biometric identification. [Data Collection]

This list was generated on Mon May 23 02:23:52 2022 BST.